Search Results - "GINGRICH, J. R"

Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer by ARMSTRONG, A. J, HAGGMAN, M, CARDUCCI, M. A, PILI, R, STADLER, W. M, GINGRICH, J. R, ASSIKIS, V, POLIKOFF, J, DAMBER, J. E, BELKOFF, L, NORDLE, Ö, FORSBERG, G

“…Tasquinimod (Active Biotech) is an oral immunomodulatory, anti-angiogenic, and anti-metastatic agent that delayed metastatic disease progression in a…”
Get full text

Pathologic progression of autochthonous prostate cancer in the TRAMP model by Gingrich, J R, Barrios, R J, Foster, B A, Greenberg, N M

“…The ability to manipulate gene expression in specific cell types at specific times utilizing transgenic technology has allowed the development of novel mouse…”
Get full text

Ethics of postmortem sperm retrieval : Ethics of sperm retrieval after death or persistent vegetative state by STRONG, C, GINGRICH, J. R, KUTTEH, W. H

Get full text

Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice by Foster, Barbara A., Evangelou, Andreas, Kaplan, Paula J., DeMayo, Franco, Greenberg, Norman M., Gingrich, J.R.

“…The minimal rat probasin (PB) promoter was used to target expression of human fibroblast growth factor-7 (FGF-7)/keratinocyte growth factor (KGF) directly to…”
Get full text

A transgenic mouse prostate cancer model by Gingrich, J R, Greenberg, N M

Get more information

Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model by FOSTER, B. A, GINGRICH, J. R, KWON, E. D, MADIAS, C, GREENBERG, N. M

“…To develop a syngeneic transplantable system to study immunotherapeutic approaches for the treatment of prostate cancer, three cell lines were established from…”
Get full text

Metastatic prostate cancer in a transgenic mouse by GINGRICH, J. R, BARRIOS, R. J, MORTON, R. A, BOYCE, B. F, DEMAYO, F. J, FINEGOLD, M. J, ANGELOPOULOU, R, ROSEN, J. M, GREENBERG, N. M

“…We have previously reported the development of a transgenic mouse model for prostate cancer derived from PB-Tag transgenic line 8247, henceforth designated the…”
Get full text

Androgen-independent prostate cancer progression in the TRAMP model by GINGRICH, J. R, BARRIOS, R. J, KATTAN, M. W, NAHM, H. S, FINEGOLD, M. J, GREENBERG, N. M

“…We previously established the autochthonous transgenic adenocarcinoma mouse prostate (TRAMP) model to facilitate characterization of molecular mechanisms…”
Get full text

Imaging findings of hemorrhagic cystitis in pediatric oncology patients by MCCARVILLE, M. B, HOFFER, F. A, GINGRICH, J. R, JENKINS, J. J

Get full text

Inducible gene expression in the nervous system of transgenic mice by GINGRICH, J. R, RODER, J

“…Gene function during mammalian development is often studied by making irreversible changes to the genome. This approach has a major drawback in that the…”
Get full text

Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1) by Gingrich, J R, Tucker, J A, Walther, P J, Day, J W, Poulton, S H, Webb, K S

“…A new human prostate adenocarcinoma cell line (DuPro-1) has been established from the athymic nude mouse supported xenograft DU5683. This was accomplished by…”
Get more information

The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer by Keane, T E, Rosner, G L, Gingrich, J R, Poulton, S H, Walther, P J

“…Using an in vivo assay of tumor cytotoxicity (the subrenal capsule assay in nude mice), two therapeutic strategies for the treatment of advanced human…”
Get more information

Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer by Smaldone, M C, Gingrich, J R

Get more information

Strategies to enhance the efficacy of intravescical therapy for non-muscle invasive bladder cancer by Smaldone, M C, Gayed, B A, Tomaszewski, J J, Gingrich, J R

“…Transitional cell carcinoma (TCC) is the second most common urologic malignancy, and 70% of patients present with superficial, or non-muscle invasive disease…”
Get more information

Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome by Hale, G.A, Rochester, R.J, Heslop, H.E, Krance, R.A, Gingrich, J.R, Benaim, E, Horwitz, E.M, Cunningham, J.M, Tong, X, Srivastava, D.K, Leung, W.H, Woodard, P, Bowman, L.C, Handgretinger, R

“…Hemorrhagic cystitis (HC) is a well-documented adverse event experienced by patients undergoing hematopoietic stem cell transplantation. When severe, HC causes…”
Get full text

Src in synaptic transmission and plasticity by Kalia, Lorraine V, Gingrich, Jeffrey R, Salter, Michael W

“…In the central nervous system (CNS), Src and other Src family kinases are widely expressed and are abundant in neurons. Src has been implicated in…”
Get full text

The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy? by Gingrich, J R, Paulson, D F

“…Despite a negative metastatic evaluation, up to 100% of patients with high-grade tumors are found to harbor metastatic disease within the pelvic lymph nodes at…”
Get more information

Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer : analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model by KEANE, T. E, GINGRICH, J. R, ROSNER, G, WEBB, K. S, POULTON, S. H, WALTHER, P. J

“…An in vivo study of cisplatin (CDDP) and 5-fluorouracil (5FU) cytotoxicity was performed using a multidose matrix with a human bladder transitional cell…”
Get full text

Investigation of phosphoprotein signatures of archived prostate cancer tissue specimens via proteomic analysis by Chen, Li, Fang, Bin, Giorgianni, Francesco, Gingrich, Jeffrey R., Beranova-Giorgianni, Sarka

“…Early detection of prostate cancer and determination of its aggressiveness are critical factors that influence treatment outcomes. To aid in the clinical…”
Get full text

A gene hunting we will go by Gingrich, J R, Steiner, M S

“…Two general approaches toward the identification of new genes which may contribute to specific developmental, physiologic, or pathologic processes can be…”
Get full text